Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Benitec Biopharma (BNTC) Other Accumulated Expenses: 2019-2024

Historic Other Accumulated Expenses for Benitec Biopharma (BNTC) over the last 6 years, with Jun 2024 value amounting to $138,000.

  • Benitec Biopharma's Other Accumulated Expenses rose 98.73% to $157,000 in Q1 2025 from the same period last year, while for Mar 2025 it was $157,000, marking a year-over-year increase of 98.73%. This contributed to the annual value of $138,000 for FY2024, which is 100.00% up from last year.
  • Benitec Biopharma's Other Accumulated Expenses amounted to $138,000 in FY2024, which was up 100.00% from $69,000 recorded in FY2023.
  • In the past 5 years, Benitec Biopharma's Other Accumulated Expenses ranged from a high of $201,000 in FY2020 and a low of $69,000 during FY2023.
  • Over the past 3 years, Benitec Biopharma's median Other Accumulated Expenses value was $71,000 (recorded in 2022), while the average stood at $92,667.
  • Per our database at Business Quant, Benitec Biopharma's Other Accumulated Expenses skyrocketed by 164.47% in 2020 and then tumbled by 42.79% in 2021.
  • Benitec Biopharma's Other Accumulated Expenses (Yearly) stood at $201,000 in 2020, then plummeted by 42.79% to $115,000 in 2021, then plummeted by 38.26% to $71,000 in 2022, then declined by 2.82% to $69,000 in 2023, then skyrocketed by 100.00% to $138,000 in 2024.